02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

312 JUNIPER<br />

Dermatitis<br />

(1996): Meding B+, Contact Dermatitis 34(3), 185<br />

Edema<br />

Erythema<br />

Sensitivity (sic)<br />

(2001): Int J Toxicol 20, 41<br />

Vesiculation<br />

KANAMYCIN<br />

Trade names: Kanamicina; Kanamycine; Kanamytrex; Kanescin;<br />

Kannasyn; Kantrex; R<strong>and</strong>ikan<br />

Indications: Various infections caused by susceptible organisms<br />

Category: Antibiotic, aminoglycoside<br />

Half-life: 2–4 hours<br />

Clinically important, potentially hazardous interactions<br />

with: aldesleukin, atracurium, bumetanide, doxacurium,<br />

ethacrynic acid, furosemide, methoxyflurane, non-depolarizing<br />

muscle relaxants, pancuronium, polypeptide antibiotics,<br />

rocuronium, succinylcholine, torsemide, vecuronium<br />

Reactions<br />

Skin<br />

Burning<br />

Dermatitis (systemic)<br />

(1986): Holdiness MR, Contact Dermatitis 15, 282<br />

Edema (>10%)<br />

Erythema (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!